Furkan Çakır
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 04, 2026
New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors.Pelin Tokalı, Ayşe Merve Şenol, Şeyma Ateşoğlu
|Jan 08, 2026
Rational design of phenyl 2,4,5-trichlorobenzenesulfonate based thiosemicarbazones as α-glucosidase and α-amylase inhibitors: integrating enzymatic evaluation and molecular modeling.Faiqa Noreen, Magdi E A Zaki, Nastaran Sadeghian
|Oct 15, 2025
Targeting Lung Cancer: Synthesis, Characterization, Enzyme Inhibition, and Antiproliferative Activity of 1H-Benzo[f]chromen-1-One-Thiosemicarbazones Supported by Molecular Docking.Shahid Raza, Muhammad Islam, Furkan Çakır
|Sep 03, 2025
Synthesis, Characterization, and Comprehensive In Vitro and In Silico Evaluation of the Anti-Inflammatory Potential of Novel 1,2,3-Triazole-Arylidenehydrazide/Thiazolidinone Hybrids.Nihan Aktaş Pepe, Furkan Çakır, Tuğba Atalay
|Jul 10, 2025
2-Propyl-3-Aminoquinazoline-4(3H)-one Derivatives as Potential Androgen Receptor Inhibitors: Synthesis and Cytotoxicity Against PC3 Cell Line via In Vitro and In Silico Studies.Halil Şenol, Furkan Çakır, Şeyma Ateşoğlu
Pageof 1
Frequent Collaborators
5 joint publications
Halil Şenol
3 joint publications
Feyzi Sinan Tokalı
2 joint publications
Zahid Shafiq
1 joint publications
Büşra Acar
1 joint publications
Alaattin Şen
1 joint publications
Muhammad Islam
1 joint publications
Parham Taslimi
1 joint publications
İlhami Gülçin
1 joint publications
Sobhi M Gomha
1 joint publications
Pelin Tokalı
